Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis

Vaccine

Volumn 26, Issue 23, 2008, Pages 2899-2905

  Morales, Julio ^a   Martínez, José Juan ^a   Manoutcharian, Karen ^a   Hernández, Marisela ^a   Fleury, Agnes ^b   Gevorkian, Goar ^a   Acero, Gonzalo ^a   Blancas, Abel ^a   Toledo, Andrea ^a   Cervantes, Jacquelynne ^a   Maza, Victor ^c   Quet, Fabrice ^d   Bonnabau, Henri ^d   de Aluja, Aline S ^a   Fragoso, Gladis ^a   Larralde, Carlos ^a   Sciutto, Edda ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c Secretaria de Desarrollo Agropecuario   (Mexico)

^d UNIVERSITÉ DE LIMOGES   (France)

Author keywords

Control; Taenia solium cysticercosis; Vaccine

Indexed keywords

ANTIINFECTIVE AGENT; PLACEBO; S3PVAC PHAGE VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CONTROLLED STUDY; CYSTICERCOSIS; DRUG EFFICACY; ENVIRONMENTAL FACTOR; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; MALE; MEXICO; NONHUMAN; PRIORITY JOURNAL; SAMPLE SIZE; SEX DIFFERENCE; SWINE; TAENIA SOLIUM; VACCINATION; WEIGHT GAIN;

AGING; ANIMALS; ANTIGENS, HELMINTH; BACTERIOPHAGE M13; CYSTICERCOSIS; MEXICO; RURAL POPULATION; SWINE; SWINE DISEASES; TAENIA SOLIUM; VACCINES; VACCINES, INACTIVATED; WEIGHT GAIN;

EID: 43449113855     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.03.042     Document Type: Article

References (30)

1. Morales J., Martinez J.J., Garcia-Castella J., Peña N., Maza V., Villalobos N., et al. Taenia solium: the complex interactions, of biological, social, geographical and commercial factors, involved in the transmission dynamics of pig cysticercosis in highly endemic areas. Ann Trop Med Parasitol 100 2 (2006) 123-135
2. Rodriguez-Canul R., Fraser A., Allan J.C., Dominguez-Alpizar J.L., Argaez-Rodriguez F., and Craig P.S. Epidemiological study of Taenia solium taeniasis/cysticercosis in a rural village in Yucatan State, Mexico. Ann Trop Med Parasitol 83 (1999) 57-67
3. Fleury A., Morales J., Bobes R.J., Dumas M., Yanez O., Pina J., et al. An epidemiological study of familial neurocysticercosis in an endemic Mexican community. Trans R Soc Trop Med Hyg 100 (2006) 551-558
4. Montano S.M., et al., Cysticercosis Working Group in Peru. Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology 65 2 (2005) 229-233
5. Rodriguez-Hidalgo R., Benitez-Ortiz W., Praet N., Saa L.R., Vercruysse J., Brandt J., et al. Taeniasis-cysticercosis in Southern Ecuador: assessment of infection status using multiple laboratory diagnostic tools. Mem Inst Oswaldo Cruz 101 7 (2006) 779-782
6. Preux P.M., and Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurol 4 1 (2005) 21-31
7. DeGiorgio C.M., Medina M.T., Duron R., Zee C., and Escueta S.P. Neurocysticercosis. Epilepsy Curr 4 (2004) 107-111
8. De la Garza Y., Graviss E.A., Daver N.G., Gambarin K.J., Shandera W.X., Schantz P.M., et al. Epidemiology of neurocysticercosis in Houston, Texas. Am J Trop Med Hyg 73 4 (2005) 766-770
9. Sorvillo F.J., DeGiorgio C., and Watermant S.H. Deaths from cysticercosis United States. Emerg Infect Dis 13 (2007) 230-235
10. Sciutto E., Fragoso G., Fleury A., Laclette J.P., Sotelo J., Aluja A., et al. Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions. Microbes Infect 2 (2000) 1875-1890
11. Pawlowski Z.S., Allan J., and Sarti E. Control of Taenia solium taeniasis/cysticercosis: from research towards implementation. Int J Parasitol 35 (2005) 1221-1232
12. Nash T.E., Singh G., White A.C., Rajshekhar V., Loeb J.A., Proano J.V., et al. Treatment of neurocysticercosis: current status and future research needs. Neurology 67 7 (2006) 1120-1127
13. Levine M.Z., Lewis M.M., Rodriquez S., Jimenez J.A., Khan A., Lin S., et al. Development of an enzyme-linked immunoelectrotransfer blot (EITB) assay using two baculovirus expressed recombinant antigens for diagnosis of Taenia solium taeniasis. J Parasitol 93 2 (2007) 409-417
14. Serpa J.A., Yancey L.S., and White Jr. A.C. Advances in the diagnosis and management of neurocysticercosis. Expert Rev Anti Infect Ther 4 6 (2006) 1051-1061
15. Sciutto E., Rosas G., Hernandez M., Morales J., Cruz-Revilla C., Toledo A., et al. Improvement of the synthetic tri-peptide vaccine (S3Pvac) against porcine Taenia solium cysticercosis in search of a more effective, inexpensive and manageable vaccine. Vaccine 25 8 (2007) 1368-1378
16. Huerta M., de Aluja A.S., Fragoso G., Toledo A., Villalobos N., Hernandez M., et al. Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine 20 (2001) 262-266
17. Manoutcharian K., Diaz-Orea A., Gevorkian G., Fragoso G., Acero G., Gonzalez E., et al. Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Vet Immunol Immunopathol 99 (2004) 11-24
18. Del Rey A., Roggero E., Randolf A., Mahuad C., McCann S., Rettori V., et al. IL-1 resets glucose homeostasis at central levels. Proc Natl Acad Sci USA 103 43 (2006) 16039-16044
19. Sciutto E., Morales J., Martínez J.J., Toledo A., Villalobos M.N., Cruz-Revilla C., et al. Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico. Parasitology 134 (2007) 129-133
20. Manoutcharian K., Terrazas L.I., Gevorkian G., Acero G., Petrossian P., Rodriguez M., et al. Phage-displayed T-cell epitope grafted into immunoglobulin heavy-chain complementary-determining regions: an effective vaccine design tested in murine cysticercosis. Infect Immun 67 9 (1999) 4764-4770
21. Lemeshow S., Hosmer D.W., Janella K., and Lwanga S.K. Adequacy of sample size in health studies (1990), John Wiley & Sons Ltd.
22. Elashoff J.D., and Lemeshow S. Sample size determination in epidemiologic studies. In: Ahrens W., and Pigeot J. (Eds). Handbook of epidemiology (2004), Springer, Berlin/Heidelberg 559-594
23. Moher D., Schulz K.F., and Altman D.G. For the CONSORT Group, The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357 (2001) 1191-1194
24. Heesterbeek J.A., and Roberts M.G. Threshold quantities for helminth infections. Math Biol 33 4 (1995) 415-434
25. Morales-Montor J., and Larralde C. The role of sex steroids in the complex physiology of the host-parasite relationship: the case of the larval cestode of Taenia crassiceps. Parasitology 131 Pt 3 (2005) 287-294
26. Morales J., Velasco T., Tovar V., Fragoso G., Fleury A., Beltran C., et al. Castration and pregnancy of rural pigs significantly increase the prevalence of naturally acquired Taenia solium cysticercosis. Vet Parasitol 108 (2002) 41-48
27. Peña N., Morales J., Morales-Montor J., Vargas-Villavicencio A., Fleury A., Zarco L., et al. Impact of naturally acquired Taenia solium cysticercosis on the hormonal levels of free ranging boars. Vet Parasitol 149 1-2 (2007) 134-137
28. Del Brutto O.H., García E., Talámas O., and Sotelo J. Sex-related severity of inflammation in parenchymal brain cysticercosis. Arch Intern Med 148 3 (1988) 544-546
29. Larralde C., Montoya R.M., Sciutto E., Diaz M.L., Govezensky T., and Coltorti E. Deciphering western blots of tapeworm antigens (Taenia solium, Echinococcus granulosus, and Taenia crassiceps) reacting with sera from neurocysticercosis and hydatid disease patients. Am J Trop Med Hyg 40 (1989) 282-290
30. Fleury A., Dessein A., Preux P.M., Dumas M., Tapia G., Larralde C., et al. Symptomatic human neurocysticercosis-age, sex and exposure factors relating with disease heterogeneity. J Neurol 251 7 (2004) 830-837